I think Takeda's Alofisel® sales / royalties will be interesting as time goes on more so than JCR's Temcell® growth.... Temcell® 's growth will probably taper off during the same period unless they start using it to treat other medical conditions outside of GVHD ?
I would also add that Alofisel® is slowly being released internationally as approvals are obtained whereas in comparison to Temcell® which is currently limited to one country - Japan
I think Takeda's Alofisel® sales / royalties will be interesting...
-
- There are more pages in this discussion • 474 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10425 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 44243 | 5 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |